Skip to content

Member

Ingeborg TER LAAK

EPP · Netherlands

Group
EPP PPE
Country
Netherlands
Roll-call participation
99.4 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
96.9 %ⓘ of 616 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
CDA Christen Democratisch Appèl
In office
Since 16 Jul 2024
Against clear line
16 of 573 votesⓘ
Committees
AFET (substitute), ENVI, SANT (substitute)
Member id
256968
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

99.4 %

616 of 620 final votes while in office

EPP median: 90.6 % (+8.8 pts)

Chamber median: 90.6 %

With majority line ⓘ

96.9 %

597 of 616 votes where their group had a line

EPP median: 95.6 % (+1.4 pts)

Against clear line ⓘ

2.8 %

16 of 573 votes where their group had a clear line

3 opposite (for ↔ against), 13 abstained against the line

Abstention ⓘ

2.3 %

14 of 616 votes cast

Participation 99.4 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Ingeborg TER LAAK99.4 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 96.9 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Ingeborg TER LAAK96.9 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: Against Majority line: Against
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 0 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Willemien KONING EPPNetherlands100 % of 1 910 shared89 %
Jeroen LENAERS EPPNetherlands100 % of 5 865 shared89 %
Tom BERENDSEN Former memberEPPNetherlands100 % of 3 742 shared89 %
Manfred WEBER EPPGermany97 % of 4 621 shared89 %
Siegfried MUREŞAN EPPRomania97 % of 5 626 shared89 %
Christine SCHNEIDER Former memberEPPGermany96 % of 3 666 shared89 %
Pekka TOVERI EPPFinland96 % of 5 208 shared89 %
Rasa JUKNEVIČIENĖ EPPLithuania96 % of 4 803 shared89 %
Sven SIMON EPPGermany96 % of 4 740 shared89 %
Mika AALTOLA EPPFinland96 % of 4 893 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia89 % of 5 273 shared82 %
Jeannette BALJEU RenewNetherlands88 % of 5 170 shared82 %
Bart GROOTHUIS RenewNetherlands88 % of 4 426 shared82 %
Dan BARNA RenewRomania88 % of 5 170 shared82 %
Andreas GLÜCK RenewGermany88 % of 3 941 shared82 %
Jan-Christoph OETJEN RenewGermany88 % of 5 703 shared82 %
Hilde VAUTMANS RenewBelgium88 % of 5 696 shared82 %
Malik AZMANI RenewNetherlands88 % of 5 818 shared82 %
Katri KULMUNI RenewFinland87 % of 4 654 shared82 %
Elsi KATAINEN RenewFinland87 % of 5 757 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Foreign AffairsAFET CommitteeSubstitute19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with the United StatesD-US DelegationSubstitute19 Sept 2024now
Delegation for relations with the Pan-African ParliamentDPAP DelegationSubstitute8 Oct 2024now
Delegation to the OACPS-EU Joint Parliamentary AssemblyDACP Parliamentary assemblyVice-chair3 Oct 2024now
Delegation to the Africa-EU Parliamentary AssemblyDAFR Parliamentary assemblyVice-chair30 Sept 2024now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationENVI24 Jun 2026
No dossier namedDelegation vice-chairDAFR5 May 2026
Suspending the application of the rules on the appointment of an authorised representative for extended producer responsibility for batteries and waste batteries and packaging and packaging wasteRapporteurENVI11 Mar 2026
Suspending the application of the rules on the appointment of authorised representatives for extended producer responsibility for waste, waste electrical and electronical equipment and single use plastic wasteRapporteurENVI11 Mar 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurSANT11 Mar 2026
Implementation and delivery of the Sustainable Development Goals in view of the 2026 High-Level Political ForumShadow rapporteurENVI11 Mar 2026
Recommendation to the Council, the Commission and the Vice-President of the Commission / High Representative of the Union on Foreign Affairs and Security Policy on promoting transnational governance on water in the interests of conflict prevention and peaceShadow rapporteurAFET24 Feb 2026
No dossier namedOfficial delegationAFET29 Jan 2026
Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activitiesShadow rapporteur for an opinionENVI14 Jan 2026
EP ad hoc delegation to Midrand, South Africa (for the Pre-AU–EU Summit Parliamentary Meeting, 14-15 November 2025)Official delegationDACP10 Nov 2025

Show all 19 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

60 contributions recorded; 8 on behalf of their group; 80 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026The impact of the implementation of the Packaging and Packaging Waste Regulation (PPWR) on SMEs, its administrative burden and challenges for the European Single Market (debate) SpeechRead
16 Sept 2026The impact of the implementation of the Packaging and Packaging Waste Regulation (PPWR) on SMEs, its administrative burden and challenges for the European Single Market (debate) Speech · 1 minRead
8 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Speech · 1 minRead
8 Jul 2026Harnessing the potential of a competitive and sustainable EU Bioeconomy Strategy for EU strategic autonomy (debate) Speech · 1 minRead
8 Jul 2026Ebola outbreak in the Democratic Republic of the Congo and Uganda: EU solidarity and preparedness in global health (debate) Speech · 1 minRead
7 Jul 20262025 Commission report on Ukraine (debate) Speech · 1 minRead
16 Jun 2026An EU future for the Western Balkans (joint debate) SpeechRead
16 Jun 2026An EU future for the Western Balkans (joint debate) Speech · 1 minRead
16 Jun 2026The role of the EU in efforts for peace and stability throughout the Middle East after the announced deal between the US and Iran (debate) Speech · 1 minRead
20 May 2026Situation of women and girls in Afghanistan following the Taliban's adoption of the Criminal Procedure Code for Courts Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 83

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026MOTION FOR A RESOLUTION on Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya B-10-2026-0418Motion for a resolutionwith 25 co-authors—
14 Sept 2026MOTION FOR A RESOLUTION The deteriorating situation of media freedom and freedom of expression in Hong-Kong, amid the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung B-10-2026-0405Motion for a resolutionwith 23 co-authors—
14 Sept 2026MOTION FOR A RESOLUTION Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro B-10-2026-0394Motion for a resolutionwith 27 co-authors—
14 Sept 2026Circular Economy Act: regulatory barriers to secondary raw materials E-10-2026-003654Written questionwith 29 co-authorsNot yet answered
6 Jul 2026MOTION FOR A RESOLUTION on the abduction, forced conversion and child marriage of Maria Shahbaz and the protection of girls in Pakistan B-10-2026-0350Motion for a resolutionwith 27 co-authors—
6 Jul 2026MOTION FOR A RESOLUTION on the threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan B-10-2026-0362Motion for a resolutionwith 25 co-authors—
6 Jul 2026MOTION FOR A RESOLUTION on the ongoing persecution of Christians in Nigeria, notably the Kawel village massacre B-10-2026-0355Motion for a resolutionwith 27 co-authors—
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
19 Jun 2026Ban the butt: it is time to stub out cigarette filters E-10-2026-002547Written questionwith 9 co-authors3 Sept 2026
16 Jun 2026MOTION FOR A RESOLUTION on Deteriorating situation of political prisoners in Belarus, in particular the case of Aliaksandra Pulinovich B-10-2026-0328Motion for a resolutionwith 28 co-authors—

Show all 83 questions and motions

Amendments tabled in committee, 40

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT35
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ538
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ533
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ534
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ538

Show all 40 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Ingeborg TER LAAK”. Member record. memberId 256968. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256968?page=4&scope=final&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256968. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256968?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256968,
  author = {{EU Parl Watch Research}},
  title = {{Ingeborg TER LAAK}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256968?page=4&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/256968?page=4&scope=final&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256968. Official source: https://www.europarl.europa.eu/meps/en/256968. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}